BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

57 related articles for article (PubMed ID: 30194676)

  • 1. Comparison analysis between haplo identical stem cell transplantation and matched sibling donor stem cell transplantation for high-risk acute myeloid leukemia in first complete remission.
    Liu Y; Huang X; Fei Q; Xu L; Zhang X; Liu K; Chen Y; Chen H; Wang Y
    Sci China Life Sci; 2019 May; 62(5):691-697. PubMed ID: 30194676
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Matched and mismatched unrelated donor compared to autologous stem cell transplantation for acute myeloid leukemia in first complete remission: a retrospective, propensity score-weighted analysis from the ALWP of the EBMT.
    Saraceni F; Labopin M; Gorin NC; Blaise D; Tabrizi R; Volin L; Cornelissen J; Cahn JY; Chevallier P; Craddock C; Wu D; Huynh A; Arcese W; Mohty M; Nagler A;
    J Hematol Oncol; 2016 Sep; 9(1):79. PubMed ID: 27589849
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Comparison of matched sibling donors versus unrelated donors in allogeneic stem cell transplantation for primary refractory acute myeloid leukemia: a study on behalf of the Acute Leukemia Working Party of the EBMT.
    Brissot E; Labopin M; Stelljes M; Ehninger G; Schwerdtfeger R; Finke J; Kolb HJ; Ganser A; Schäfer-Eckart K; Zander AR; Bunjes D; Mielke S; Bethge WA; Milpied N; Kalhs P; Blau IW; Kröger N; Vitek A; Gramatzki M; Holler E; Schmid C; Esteve J; Mohty M; Nagler A
    J Hematol Oncol; 2017 Jun; 10(1):130. PubMed ID: 28646908
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Matched related versus unrelated versus haploidentical donors for allogeneic transplantation in AML patients achieving first complete remission after two induction courses: a study from the ALWP/EBMT.
    Nagler A; Labopin M; Mielke S; Passweg J; Blaise D; Gedde-Dahl T; Cornelissen JJ; Salmenniemi U; Yakoub-Agha I; Reményi P; Socié G; van Gorkom G; Labussière-Wallet H; Huang XJ; Rubio MT; Byrne J; Craddock C; Griškevičius L; Ciceri F; Mohty M
    Bone Marrow Transplant; 2023 Jul; 58(7):791-800. PubMed ID: 37045942
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Autologous versus unrelated donor stem cell transplantation for adults with primary acute myeloid leukemia in first remission].
    Yao JF; Zhang GX; Yang DL; He Y; Wei JL; Zhai WH; Jiang EL; Zhang RL; Feng SZ; Han MZ
    Zhonghua Xue Ye Xue Za Zhi; 2020 May; 41(5):365-372. PubMed ID: 32536132
    [No Abstract]   [Full Text] [Related]  

  • 6. Comparison of Allogeneic Transplant Outcomes Between Matched Sibling Donors and Alternative Donors in Patients Over 50 Years of Age with Acute Myeloid Leukemia: 8/8 Allele-Matched Unrelated Donors and Unrelated Cord Blood Provide Better Leukemia-Free Survival Compared with Matched Sibling Donors During Nonremission Status.
    Konuma T; Yamasaki S; Ishiyama K; Mizuno S; Hayashi H; Uchida N; Shimabukuro M; Tanaka M; Kuriyama T; Onizuka M; Ishiwata K; Sawa M; Tanaka T; Ohigashi H; Fujiwara SI; Matsuoka KI; Ota S; Nishida T; Kanda Y; Fukuda T; Atsuta Y; Nakasone H; Yanada M;
    Transplant Cell Ther; 2024 Feb; 30(2):215.e1-215.e18. PubMed ID: 38081415
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Allogeneic hematopoietic cell transplantation for older patients with AML with active disease. A study from the Acute Leukemia Working Party of the European Society for Blood and Marrow Transplantation (EBMT).
    Maffini E; Labopin M; Kröger N; Finke J; Stelljes M; Schroeder T; Einsele H; Tischer J; Bornhäuser M; Bethge W; Brecht A; Rösler W; Dreger P; Schäfer-Eckart K; Passweg J; Blau IW; Nagler A; Ciceri F; Mohty M
    Bone Marrow Transplant; 2024 Mar; ():. PubMed ID: 38555412
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Allogeneic hematopoietic stem cell transplantation: A single-center experience, 2017 to 2021.
    da Silva PCL; Muzzi GC; Vilela MR; Fabreti-Oliveira RA
    Transpl Immunol; 2024 Feb; 82():101989. PubMed ID: 38199270
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Comparison of autologous, matched sibling, and alternative donor stem cell transplant outcomes for acute myeloid leukemia patients in first remission: A propensity score matching study.
    Wang M; Zhang H; Zheng X; Liu J; Wang J; Cao Y; Zhang X; Zhang R; Chen X; Zhai W; Ma Q; Wei J; Huang Y; Yang D; He Y; Pang A; Feng S; Han M; Jiang E
    Hematol Oncol; 2024 Jan; 42(1):e3230. PubMed ID: 37752767
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Donor matters: Donor selection impact on hematopoietic stem cell transplantation outcomes in Hispanic patients with B-cell acute lymphocytic leukemia: Insights from a myeloablative HSCT study.
    Ashouri K; Ginosyan AA; Chu M; Hom B; Hwang J; Resnick K; Rahimi Y; Chaudhary P; Woan K; Siddiqi I; Ladha A; Ali A; Tam EL; Yaghmour G
    Leuk Res; 2024 Jun; 141():107501. PubMed ID: 38631149
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Haploidentical and matched unrelated donor allogeneic hematopoietic stem cell transplantation offer similar survival outcomes for acute leukemia.
    Wang YC; Lai CL; Chen TC; Gau JP; Teng CJ
    Cancer Rep (Hoboken); 2024 Apr; 7(4):e2060. PubMed ID: 38600053
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Efficacy and Prognostic Factors of Nonmyeloablative Allogeneic Hematopoietic Stem Cell Transplantation for Patients with Acute Myeloid Leukemia].
    Shi YP; Cai B; Yu CL; Qiao JH; Chen XR; Lei YY; Wang Y; Yao B; Li BX; Liu TQ; Ai HS; Guo M
    Zhongguo Shi Yan Xue Ye Xue Za Zhi; 2023 Dec; 31(6):1852-1859. PubMed ID: 38071072
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Efficacy of Activated Autologous Hematopoietic Stem Cell Transplantation in the Treatment of Acute Myeloid Leukemia].
    Ren RR; Ma LM; Wang T; Xie YX; Zhu QJ; Gao ZL; Tian WW; Gong R; Niu YY
    Zhongguo Shi Yan Xue Ye Xue Za Zhi; 2023 Auguest; 31(5):1509-1515. PubMed ID: 37846709
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Dynamic immune profiling identifies the stronger graft-versus-leukemia (GVL) effects with haploidentical allografts compared to HLA-matched stem cell transplantation.
    Guo H; Chang YJ; Hong Y; Xu LP; Wang Y; Zhang XH; Wang M; Chen H; Chen YH; Wang FR; Wei-Han ; Sun YQ; Yan CH; Tang FF; Mo XD; Liu KY; Huang XJ
    Cell Mol Immunol; 2021 May; 18(5):1172-1185. PubMed ID: 33408344
    [TBL] [Abstract][Full Text] [Related]  

  • 15. G-CSF-Primed Peripheral Blood Stem Cell Haploidentical Transplantation Could Achieve Satisfactory Clinical Outcomes for Acute Leukemia Patients in the First Complete Remission: A Registered Study.
    Ma YR; Zhang X; Xu L; Wang Y; Yan C; Chen H; Chen Y; Han W; Wang F; Wang J; Liu K; Huang X; Mo X
    Front Oncol; 2021; 11():631625. PubMed ID: 33791217
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Matched unrelated donor transplantation versus haploidentical transplantation with post-transplant cyclophosphamide in children with acute myeloid leukemia: a PDWP-EBMT study.
    Ruggeri A; Santoro N; Galimard JE; Kalwak K; Algeri M; Zubarovskaya L; Czyzewski K; Skorobogatova E; Sedlacek P; Besley C; Balduzzi A; Bertrand Y; Peristeri J; Fagioli F; Ifversen M; Gozdzik J; Peters C; Versluijs B; Biffi A; Prete A; Faraci M; Ghemlas I; Bodova I; Aleinikova O; Dalissier A; Rocha V; Corbacioglu S
    Haematologica; 2024 Jan; ():. PubMed ID: 38186346
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Comparison of transplant outcomes between haploidentical transplantation and single cord blood transplantation in non-remission acute myeloid leukaemia: A nationwide retrospective study.
    Matsuda K; Konuma T; Fuse K; Masuko M; Kawamura K; Hirayama M; Uchida N; Ikegame K; Wake A; Eto T; Doki N; Miyakoshi S; Tanaka M; Takahashi S; Onizuka M; Kato K; Kimura T; Ichinohe T; Takayama N; Kobayashi H; Nakamae H; Atsuta Y; Kanda J; Yanada M
    Br J Haematol; 2023 Apr; 201(1):106-113. PubMed ID: 36281887
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Haploidentical and Matched Sibling Transplantation for Acute Myeloid Leukemia: A Hospital-Based Study.
    Baena JC; Rosales MC; Estacio M; Hidalgo A; Arrieta E; Jaramillo FJ; Manzi E; Parra-Lara LG; Rosales JD
    J Hematol; 2023 Dec; 12(6):255-267. PubMed ID: 38188474
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Comparison of clinical features of hemorrhagic cystitis after haploidentical and matched sibling donor allogeneic hematopoietic stem cell transplantation].
    Zheng FM; Fu HX; Han TT; Wang FR; Wang JZ; Chen Y; Yan CH; Zhang YY; Han W; Chen YY; Chen H; Wang Y; Zhang XH; Liu KY; Huang XJ; Xu LP
    Zhonghua Xue Ye Xue Za Zhi; 2017 Aug; 38(8):656-661. PubMed ID: 28954342
    [No Abstract]   [Full Text] [Related]  

  • 20. [Analysis of efficacy and prognosis of allogeneic hematopoietic stem cell transplantation for the treatment of combined immunodeficiency].
    Wang P; Qian XW; Jiang WJ; Wang HS; Hou J; Sun JQ; Wang XC; Zhai XW
    Zhonghua Er Ke Za Zhi; 2024 May; 62(5):444-450. PubMed ID: 38623012
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 3.